✦ LIBER ✦

Anti-Vascular Endothelial Growth Factor Receptor-1 Antagonist Antibody as a Therapeutic Agent for Cancer

✍ Scribed by Wu, Y.; Zhong, Z.; Huber, J.; Bassi, R.; Finnerty, B.; Corcoran, E.; Li, H.; Navarro, E.; Balderes, P.; Jimenez, X.; Koo, H.; Mangalampalli, V. R.M.; Ludwig, D. L.; Tonra, J. R.; Hicklin, D. J.

Book ID: 125488190
Publisher: American Association for Cancer Research
Year: 2006
Tongue: English
Weight: 642 KB
Volume: 12
Category: Article
ISSN: 1078-0432
DOI: 10.1158/1078-0432.CCR-06-0831

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A potential therapeutic strategy for cap

A potential therapeutic strategy for capillary hemangioma with new anti-vascular endothelial growth factor (anti-VEGF) agents

✍ Morsal Mehriar; Abbas Attarzadeh; Mahsa Naseri; Naser Owji; Sirus Siyoofi; Mahna 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 33 KB

Vascular endothelial growth factor recep

Vascular endothelial growth factor receptor-1 in human cancer : Concise review and rationale for development of IMC-18F1 (Human antibody targeting vascular endothelial growth factor receptor-1)

✍ Jonathan D. Schwartz; Eric K. Rowinsky; Hagop Youssoufian; Bronislaw Pytowski; Y 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 223 KB

## Abstract The human vascular endothelial growth factor receptor‐1 (VEGFR‐1, or Flt‐1) is widely expressed in normal and pathologic tissue and contributes to the pathogenesis of both neoplastic and inflammatory diseases. In human cancer, VEGFR‐1 mediated signaling is responsible for both direct tu

A Randomized Trial of Bevacizumab, an An

A Randomized Trial of Bevacizumab, an Anti–Vascular Endothelial Growth Factor Antibody, for Metastatic Renal Cancer

✍ Yang, James C.; Haworth, Leah; Sherry, Richard M.; Hwu, Patrick; Schwartzentrube 📂 Article 📅 2003 🏛 Massachusetts Medical Society 🌐 English ⚖ 176 KB

Systemic Therapy for Advanced or Metasta

Systemic Therapy for Advanced or Metastatic Colorectal Cancer: National Comprehensive Cancer Network Guidelines for Combining Anti-Vascular Endothelial Growth Factor and Anti-Epidermal Growth Factor Receptor Monoclonal Antibodies with Chemotherapy

✍ Paul F. Engstrom 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB

Therapeutic potential of ABX-EGF: A full

Therapeutic potential of ABX-EGF: A fully human anti-epidermal growth factor receptor monoclonal antibody for cancer treatment

✍ David H Lynch; Xiao-Dong Yang 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 95 KB

A Phase II Trial of Humanized Anti-Vascu

A Phase II Trial of Humanized Anti-Vascular Endothelial Growth Factor Antibody for the Treatment of Androgen-Independent Prostate Cancer

✍ David M. Reese; Paige Fratesi; Michelle Corry; William Novotny; Eric Holmgren; E 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 176 KB